F Dx Advisors, Inc. Haleon PLC Transaction History

F Dx Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$8.02 - $8.67 $29,032 - $31,385	-3,620 Reduced 7.63%	43,832 $372,000
Q4 2023 Feb 12, 2024	SELL	$7.78 - $8.62 $76,897 - $85,200	-9,884 Reduced 17.24%	47,452 $391,000
Q3 2023 Nov 02, 2023	SELL	$7.85 - $8.94 $135,074 - $153,830	-17,207 Reduced 23.08%	57,336 $477,000
Q2 2023 Jul 17, 2023	BUY	$8.04 - $9.0 $7,726 - $8,649	961 Added 1.31%	74,543 $624,000
Q4 2022 Feb 09, 2023	BUY	$5.96 - $8.06 $2,646 - $3,578	444 Added 0.61%	73,582 $589,000
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $411,766 - $548,535	73,138 New	73,138 $445,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.